Page 8 - University of Georgia

Diseases, Conditions, Syndromes

Promising path found for COVID-19 therapeutics

A team of researchers at the University of Georgia has successfully demonstrated that a set of drug-like small molecules can block the activity of a key SARS-CoV-2 protein—providing a promising path for new COVID-19 therapeutics.

Diseases, Conditions, Syndromes

UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza

Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza ...

Diseases, Conditions, Syndromes

UGA animal vaccine may slow deadly spread of Chagas disease

Chagas disease is the single most common cause of congestive heart failure and sudden death in the world. The devastating parasitic infection affects millions of people throughout Central and South America. But as global ...

Diseases, Conditions, Syndromes

Harmful bacteria can survive in sandwich crackers, cookies for months

Researchers at the University of Georgia found that pathogens like salmonella can survive for at least six months in cookies and crackers. The recent study was prompted by an increased number of outbreaks of foodborne diseases ...

Diseases, Conditions, Syndromes

New rabies vaccine could reduce cost, risk

(Medical Xpress)—Researchers at the University of Georgia used a common dog disease-canine parainfluenza-to build a new vaccine to protect humans and animals from the rabies virus. Developers hope the new treatment will ...

Oncology & Cancer

Study finds that less is more for common cancer drug

University of Georgia scientists have found that smaller, less toxic amounts of chemotherapy medicine given frequently to mice with human prostate cancer noticeably slowed tumor growth. The mice suffered fewer side effects ...

page 8 from 40